A new vaccine for glioblastoma brain cancer suspends tumor growth and is well tolerated by patients, according to the results of an early phase clinical trial.
from Neuroscience News Updates https://ift.tt/2I1NIop
from Neuroscience News Updates https://ift.tt/2I1NIop
Comments
Post a Comment